Adalimumab/Amoxicillin/clavulanic-acidLiver injury and B-lymphoblastic leukaemia

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 1993卷 / 1期
关键词：
D O I：
10.1007/s40278-024-52940-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 17
相关论文
共 31 条
  • [21] Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene
    Wouters, Yannick
    Nevejan, Louis
    Louwagie, Annelies
    Devos, Helena
    Dewaele, Barbara
    Selleslag, Dominik
    Michaux, Lucienne
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (04) : e112 - e115
  • [22] RARE PRESENTATION OF ACUTE B-LYMPHOBLASTIC LEUKAEMIA MIMICS GUILLAIN-BARRE SYNDROME: A CASE REPORT
    Chen, Wei-Cheng
    Chen, Chih-Yu
    Liang, Shinn-Jye
    Chen, Chi-Ching
    Tien, Cheng-Tsung
    Huang, Wei-Chun
    RESPIROLOGY, 2018, 23 : 138 - 138
  • [23] Sildenafil/tadalafilFirst report of acute B-lymphoblastic leukaemia secondary to bone marrow toxicity: case report
    Reactions Weekly, 2010, 1314 (1) : 38 - 38
  • [24] Prominent cytoplasmic lipid droplets in a relapsed B-lymphoblastic leukaemia/lymphoma after multiple lines of therapy
    Boham, Sampson Kwabina
    Luo, Wei
    Zhou, Jiehao
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (06) : 1025 - 1026
  • [25] MINIMAL RESIDUAL DISEASE AND B-CELL SUBPOPULATION MONITORING IN ACUTE B-LYMPHOBLASTIC LEUKAEMIA PATIENTS TREATED ON RALL-2016 PROTOCOL
    Galtseva, I., V
    Davydova, Y. O.
    Parovichnikova, E. N.
    Gavrilina, O. A.
    Troitskaya, V. V.
    Kapranov, N. M.
    Nikiforova, K. A.
    Isinova, G. A.
    Zarubina, K., I
    Sokolov, A. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (02): : 192 - 205
  • [26] CAN CD66C EXPRESSION IN B-LYMPHOBLASTIC LEUKAEMIA PREDICT THE PRESENCE OF BCR/ABL1 REARRANGEMENT?
    Ambayya, Angeli
    Awang, Rahimah
    Meng, Chang Kian
    Yegappan, Subramanian
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 13 - 13
  • [27] Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 study
    Jiang, Nan
    Wang, Lingzhi
    Xiang, Xiaoqiang
    Li, Zhenhua
    Chiew, Edwynn Kean Hui
    Koo, Yok Moi
    Lee, How Sung
    Lin, Hai Peng
    Ah Moy Tan
    Thuan Chong Quah
    Kham, Shirley Kow Yin
    Goh, Boon Cher
    Ariffin, Hany
    Yeoh, Allen Eng-Juh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1990 - 1999
  • [28] A CD10-negative adult B-lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature
    Wang, Huan-You
    St Louis, Hailee M.
    Costello, Caitlin L.
    Murray, Sarah S.
    Dell'Aquila, Marie L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 364 - 367
  • [29] Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease
    Chatterjee, Gaurav
    Sriram, Harshini
    Ghogale, Sitaram
    Deshpande, Nilesh
    Khanka, Twinkle
    Girase, Karishma
    Verma, Shefali
    Arolkar, Gauri
    Dasgupta, Niharika
    Narula, Gaurav
    Shetty, Dhanalaxmi
    Dhamne, Chetan
    Moulik, Nirmalya R.
    Rajpal, Sweta
    Patkar, Nikhil, V
    Banavali, Shripad
    Gujral, Sumeet
    Subramanian, Papagudi G.
    Tembhare, Prashant R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 374 - 379
  • [30] Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
    Reinert, Jochim
    Beitzen-Heineke, Antonia
    Wethmar, Klaus
    Stelljes, Matthias
    Fiedler, Walter
    Schwartz, Stefan
    ANNALS OF HEMATOLOGY, 2021, 100 (11) : 2727 - 2732
1234